181 related articles for article (PubMed ID: 26378999)
1. Interstitial lung disease associated with docetaxel in a patient treated for breast cancer - a case report.
Pankowska-Supryn M; Załęska M; Roszkowska-Śliż B; Roszkowski-Śliż K
Pneumonol Alergol Pol; 2015; 83(5):378-82. PubMed ID: 26378999
[TBL] [Abstract][Full Text] [Related]
2. [Fatal acute interstitial lung disease associated with docetaxel administration: about a case and review of the literature].
Brahmi SA; Youssef S; Ziani FZ; Afqir S
Pan Afr Med J; 2016; 24():119. PubMed ID: 27642457
[TBL] [Abstract][Full Text] [Related]
3. Severe interstitial pneumonitis following high-dose cyclophosphamide, thiotepa and docetaxel: two case reports and a review of the literature.
Mileshkin L; Prince HM; Rischin D; Zimet A
Bone Marrow Transplant; 2001 Mar; 27(5):559-63. PubMed ID: 11313694
[TBL] [Abstract][Full Text] [Related]
4. Lethal pneumonitis after docetaxel chemotherapy: case report and review of the literature.
Storaas E; Holmaas G; Gravdal K; Børretzen A; Eikesdal HP
Acta Oncol; 2013 Jun; 52(5):1034-8. PubMed ID: 23244676
[No Abstract] [Full Text] [Related]
5. Docetaxel-induced Haemorrhagic Interstitial Pneumonitis - An Acute Life-threatening Adverse Effect.
Chatterjee S; Pilaka VK; Mukhopadhyay S; Shrimali RK; Ahmed R
Clin Oncol (R Coll Radiol); 2015 Aug; 27(8):483-4. PubMed ID: 25911197
[No Abstract] [Full Text] [Related]
6. A commentary on interstitial pneumonitis induced by docetaxel: clinical cases and systematic review of the literature.
Genestreti G; Di Battista M; Trisolini R; Denicolò F; Valli M; Lazzari-Agli LA; Dalpiaz G; De Biase D; Bartolotti M; Cavallo G; Brandes AA
Tumori; 2015 Jun; 101(3):e92-5. PubMed ID: 25908033
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy-induced infiltrative pneumonitis cases in breast cancer patients.
Kim S; Tannock I; Sridhar S; Seki J; Bordeleau L
J Oncol Pharm Pract; 2012 Jun; 18(2):311-5. PubMed ID: 22217649
[TBL] [Abstract][Full Text] [Related]
8. Acute lung injury associated with docetaxel and bevacizumab.
Prat A; Martínez P; Serrano C; Montero MA; Andreu J; Cortés J
Clin Oncol (R Coll Radiol); 2007 Dec; 19(10):803-5. PubMed ID: 17889516
[No Abstract] [Full Text] [Related]
9. Acute interstitial pneumopathy associated with docetaxel hypersensitivity.
Karacan O; Eyüboglu FO; Akçay S; Ozyilkan O
Onkologie; 2004 Dec; 27(6):563-5. PubMed ID: 15591716
[TBL] [Abstract][Full Text] [Related]
10. Distinctive impact of pre-existing interstitial lung disease on the risk of chemotherapy-related lung injury in patients with lung cancer.
Ozawa Y; Akahori D; Koda K; Abe T; Hasegawa H; Matsui T; Tanahashi M; Niwa H; Yamada K; Yokomura K; Suda T
Cancer Chemother Pharmacol; 2016 May; 77(5):1031-8. PubMed ID: 27048413
[TBL] [Abstract][Full Text] [Related]
11. Interstitial pneumonitis in a castration-resistant prostate cancer patient receiving cabazitaxel after thoracic radiation therapy: a case report.
Yanai Y; Kosaka T; Hongo H; Oya M
BMC Cancer; 2019 Jul; 19(1):720. PubMed ID: 31331293
[TBL] [Abstract][Full Text] [Related]
12. Incidence of interstitial pneumonitis in breast cancer patients treated with pegylated liposomal doxorubicin.
Meng L; Huang L; Xu Y; Zhang W
Cancer Chemother Pharmacol; 2020 Jan; 85(1):3-7. PubMed ID: 31377831
[TBL] [Abstract][Full Text] [Related]
13. Severe interstitial pneumonitis associated with the administration of taxanes.
Nagata S; Ueda N; Yoshida Y; Matsuda H; Maehara Y
J Infect Chemother; 2010 Oct; 16(5):340-4. PubMed ID: 20354889
[TBL] [Abstract][Full Text] [Related]
14. Interstitial lung disease associated with docetaxel in patients with advanced non-small cell lung cancer.
Tamiya A; Naito T; Miura S; Morii S; Tsuya A; Nakamura Y; Kaira K; Murakami H; Takahashi T; Yamamoto N; Endo M
Anticancer Res; 2012 Mar; 32(3):1103-6. PubMed ID: 22399640
[TBL] [Abstract][Full Text] [Related]
15. Fatal interstitial lung disease associated with oral erlotinib therapy for lung cancer.
Makris D; Scherpereel A; Copin MC; Colin G; Brun L; Lafitte JJ; Marquette CH
BMC Cancer; 2007 Aug; 7():150. PubMed ID: 17683587
[TBL] [Abstract][Full Text] [Related]
16. Lungs in White Induced by Docetaxel.
Watad A; Bragazzi N; Grysman Luigi; Mahagna H; Amital H
Isr Med Assoc J; 2017 Jun; 19(6):393-394. PubMed ID: 28647942
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of doxorubicin/docetaxel/cyclophosphamide for locally advanced and metastatic breast cancer: results from NSABP trial BP-58.
Smith RE; Anderson SJ; Brown A; Scholnik AP; Desai AM; Kardinal CG; Lembersky BC; Mamounas EP
Clin Breast Cancer; 2002 Dec; 3(5):333-40. PubMed ID: 12533263
[TBL] [Abstract][Full Text] [Related]
18. Fatal interstitial pneumonitis associated with docetaxel administration in a patient with hormone-refractory prostate cancer.
Leimgruber K; Negro R; Baier S; Moser B; Resch G; Sansone S; Adami M; Zanon P; Graiff C; Egarter-Vigl E; Wiedermann CJ
Tumori; 2006; 92(6):542-4. PubMed ID: 17260498
[TBL] [Abstract][Full Text] [Related]
19. Use of doxorubicin plus cyclophosphamide followed by docetaxel as adjuvant chemotherapy for breast cancer.
Livi L; Meattini I; de Luca Cardillo C; Scotti V; Agresti B; Franzese C; Sanchez L; Nori J; Bertocci S; Cassani S; Bianchi S; Cataliotti L; Biti G
J Chemother; 2011 Feb; 23(1):36-9. PubMed ID: 21482493
[TBL] [Abstract][Full Text] [Related]
20. Primary cutaneous intravascular large B-cell lymphoma treated with combination chemotherapy and complicated by rituximab-induced interstitial lung disease.
Park GH; Kim CH; Chung WK; Won CH; Chang SE; Lee MW; Choi JH; Moon KC
Acta Derm Venereol; 2010 May; 90(3):296-8. PubMed ID: 20526551
[No Abstract] [Full Text] [Related]
[Next] [New Search]
